Name: UMIN ID:
Unique ID issued by UMIN | UMIN000027821 |
---|---|
Receipt number | R000031865 |
Scientific Title | Phase II study of allogeneic hematopoietic cell transplantation for children with acute myeloid leukemia in first and second complete remission using fludarabine, cytarabine, melphalan and low-dose total body irradiation as a conditioning regimen (AML-SCT15). |
Date of disclosure of the study information | 2017/07/01 |
Last modified on | 2017/12/19 16:16:47 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/06/19 19:41:30 | ||
2 | Update | 2017/06/23 14:48:58 | Division name |
|
3 | Update | 2017/12/19 15:49:33 | Recruitment status |
|
4 | Update | 2017/12/19 16:02:53 | Institution consideration Concealment |
|
5 | Update | 2017/12/19 16:12:22 | Organization1 Tel1 Email1 |
|
6 | Update | 2017/12/19 16:16:47 | Organization1 |